TargetMol

Raloxifene hydrochloride

Product Code:
 
TAR-T1549
Product Group:
 
Inhibitors and Activators
Supplier:
 
TargetMol
Regulatory Status:
 
RUO
Shipping:
 
cool pack
Storage:
 
-20℃
1 / 1

No additional charges, what you see is what you pay! *

CodeSizePrice
TAR-T1549-25mg25mg£101.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1549-50mg50mg£114.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1549-1mL1 mL * 10 mM (in DMSO)£117.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1549-100mg100mg£136.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
TAR-T1549-200mg200mg£168.00
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here.
Quantity:
Prices exclude any Taxes / VAT
Stay in control of your spending. These prices have no additional charges, not even shipping!
* Rare exceptions are clearly labelled (only 0.14% of items!).
Multibuy discounts available! Contact us to find what you can save.
This product comes from: United States.
Typical lead time: 10-14 working days.
Contact us for more accurate information.
  • Further Information
  • Documents
  • References
  • Show All

Further Information

Bioactivity:
Raloxifene hydrochloride is a second generation selective estrogen receptor modulator (SERM) used to prevent osteoporosis in postmenopausal women. It has estrogen agonist effects on bone and cholesterol metabolism but behaves as a complete estrogen antagonist on mammary gland and uterine tissue.
CAS:
82640-04-8
Formula:
C28H28ClNO4S
Molecular Weight:
510.05
Pathway:
Metabolism; Autophagy; Endocrinology/Hormones; ; Neuroscience
Purity:
0.98
SMILES:
Cl.Oc1ccc(cc1)-c1sc2cc(O)ccc2c1C(=O)c1ccc(OCCN2CCCCC2)cc1
Target:
Estrogen Receptor/ERR; MAO; Estrogen/progestogen Receptor; Autophagy

References

1. Obach RS, et al. Drug Metab Dispos, 2004, 32(1), 89-97. 2. Yang NN, et al. Endocrinology, 1996, 137(5), 2075-2084. 3. Black LJ, et al. J Clin Invest, 1994, 93(1), 63-69. 4. Evans G, et al. Endocrinology, 1994, 134(5), 2283-2288. 5. Sato M, et al. FASEB J, 1996, 10(8), 905-912. 6. Liu Z, Wang Y, Qin W, et al. Raloxifene alleviates amyloid???induced cytotoxicity in HT22 neuronal cells via inhibiting oligomeric and fibrillar species formation[J]. Journal of biochemical and molecular toxicology. 2019.